In a blog post from last month we discussed the myopia epidemic, the risk factors, and some of the consequences of this condition if left untreated. Recognizing there is no safe level of myopia, we are excited to offer another treatment option for our pediatric patients.
ACUVUE® Abiliti™ 1-day soft therapeutic contact lenses are now available at MVO. They have three unique features:
- Proven Efficacy: This is the first soft contact lens specifically designed to slow the progression of nearsightedness in children. Studies have shown that it may start to work in as little as 6 months, compared to non-therapeutic standard soft contact lenses.
- Pediatric Eye-Inspired Design: These contact lenses are slightly smaller in diameter than an adult lens but made from the same comfortable easy-handling material as ACUVUE® Oasys™ 1-day contact lenses – our most popular lens at MVO.
- RingBoost™ Technology: This patented design provides the therapeutic myopia-reducing benefit by focusing on light rays entering the eye peripherally (off the line of sight).
We are excited to offer this treatment to our young progressive myopia patients who are candidates for this new technology.
Our myopia treatments work – we use several evidence-based therapies, many of which can effectively reduce the increase in childhood myopia by 50%. Speak to your MVO Optometrist at your next visit to discover more about which one(s) would be most appropriate for your child.
